Management of tinea capitis in infants and children in the United States: A national survey of pediatric dermatologists.
Pediatr Dermatol
; 41(2): 263-265, 2024.
Article
in En
| MEDLINE
| ID: mdl-38342578
ABSTRACT
This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric Dermatology, revealed the following preferences fluconazole for those under 2 months, griseofulvin for those aged 2 months to 2 years, and terbinafine for those aged 2 years and older. There exists inter-provider variation in tinea capitis treatment regimens within the pediatric dermatology community.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tinea Capitis
/
Antifungal Agents
Limits:
Child
/
Humans
/
Infant
Country/Region as subject:
America do norte
Language:
En
Journal:
Pediatr Dermatol
/
Pediatr. dermatol
/
Pediatric dermatology
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: